Physician profile
Neel Bhan
NPI 1174085005
$6,088.79
in general payments reported to CMS, 2019-2025
9 companies · $5,913 in 2025
The $5,913 reported for 2025 was more than what 89% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $176 · 2025: $5,913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $1,584 · Food and Beverage: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $1,584.27 |
| Food and Beverage | $504.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,620.73 | 2025 | |
| Genzyme Corporation | $175.91 | 2024 | |
| Merck Sharp & Dohme LLC | $124.40 | 2025 | Zerbaxa |
| Astrazeneca Pharmaceuticals LP | $65.04 | 2025 | Tezspire, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.17 | 2025 | Ofev |
| Verona Pharma, INC. | $22.14 | 2025 | Ohtuvayre |
| Electromed, INC. | $22.02 | 2025 | Smartvest |
| Glaxosmithkline, LLC. | $18.37 | 2025 | Trelegy Ellipta |
| Abbvie INC. | $16.01 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neel Bhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.